Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a significant shareholder, has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent transactions.

Summary

• Saba Capital Management, L.P. has reported a change in its beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) shares.
• On February 24, 2025, Saba Capital sold 25,152 shares of common stock at a price of $15.37 per share.
• Following this transaction, Saba Capital indirectly owns 12,609,390 shares.
• On February 25, 2025, Saba Capital sold 6,179 shares of common stock at a price of $15.32 per share.
• Following this transaction, Saba Capital indirectly owns 12,603,211 shares.
• Boaz Weinstein, also associated with Saba Capital, is listed as a reporting person.
• The transactions were reported on February 26, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a major shareholder is reducing their position, which could indicate a lack of confidence or a change in investment strategy.

Negatives

• Saba Capital Management has reduced its stake in BlackRock Capital Allocation Term Trust.

Risks

• Continued selling pressure from Saba Capital could negatively impact BCAT's share price.

Industry Context

Hedge fund activity in closed-end funds like BCAT is often monitored for potential activist strategies or shifts in investment sentiment.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital reducing its stake.
• The market may interpret this as a change in sentiment towards BCAT.

Key Dates